Search
for
Sort by
Research 541–570 of 1000+
- Non-Healing Wound Model in Diabetic C57BL/6 Mice
- Білкові молекули як основа ефективних ранозагоювальних препаратів
- Wound Healing: Physiological Phases and Cellular Mechanisms.
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- Dynamic immunomodulatory nanoarchitectonics: Rewiring tissue regenerative microenvironment via intelligent regulation
- 328 The transcription factor CEBPB is a novel hub gene and multi-functional disease driver in Psoriatic skin inflammation
- The influence of vitamin C deficiency on dermatosis in neonatal dairy calves
- Life Sciences Discovery and Technology Highlights
- Employee engagement: el reto de trabajar juntos
- Editors' Picks
- An Ode to Telogen Effluvium
- Bioactivity guided isolation and characterization of the phytoconstituents from the Tridax procumbens
- Hair Loss With Rapid Weight Loss
- Erythema Nodosum Leprosum
- Towards a consensus potency assay for mesenchymal stromal cells: a matrix analysis of cell source, donor variability and inflammatory stimuli to refine surrogate markers of immunomodulation
- Folliculitis decalvans
- Cicatricial (Scarring) Alopecias
- Cicatricial alopecia
- Adipose tissue transplant in recurrent folliculitis decalvans
- Norman Orentreich, The Father of Hair Transplantation
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Circumferential acute limited exanthematous pustulosis
- Folliculitis decalvans and orofacial granulomatosis
- Missing Conflict of Interest Disclosure
- Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNF alpha transgenic mice.
- Acquired scalp alopecia. Part I: A review
- The bright side of fibroblasts: molecular signature and regenerative cues in major organs
- Hair loss during lithium treatment
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata